Pregled bibliografske jedinice broj: 1279822
Vitamin D in psoriatic arthritis – A systematic review and meta-analysis
Vitamin D in psoriatic arthritis – A systematic review and meta-analysis // Seminars in arthritis and rheumatism, 60 (2023), 152200, 10 doi:10.1016/j.semarthrit.2023.152200 (međunarodna recenzija, pregledni rad, znanstveni)
CROSBI ID: 1279822 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Vitamin D in psoriatic arthritis – A systematic
review and meta-analysis
Autori
Radić, Mislav ; Đogaš, Hana ; Kolak, Ela ; Gelemanović, Andrea ; Bučan Nenadić, Dora ; Vučković, Marijana ; Radić, Josipa
Izvornik
Seminars in arthritis and rheumatism (0049-0172) 60
(2023);
152200, 10
Vrsta, podvrsta i kategorija rada
Radovi u časopisima, pregledni rad, znanstveni
Ključne riječi
Psoriatic arthritis ; Vitamin D ; Disease activity ; Bone mineral density
Sažetak
Background: This systematic review and meta-analysis aimed to summarize current evidence on vitamin D status in patients with psoriatic arthritis (PsA) with a particular focus on disease activity. Methods: PubMed, Web of Science, Scopus and Cochrane Library databases were searched for studies that investigated vitamin D levels in PsA. The search was conducted on 12th October 2022. Included studies were cohorts, RCTs or observational studies, those assessing the level of 25(OH)D3 with control group consisting of healthy or psoriasis (Pso) patients. Nottingham-Ottawa Quality Scale was used to assess methodological quality. Random effects meta-analysis model was applied with inverse variance weighting and mean difference with 95% CI was calculated. Results: Of 356 retrieved studies, 76 duplicates and 270 studies were excluded according to the exclusion criteria with one study unavailable. Four studies including 264 PsA patients and 287 healthy controls and five studies including 225 PsA patients and 391 Pso patients assessing vitamin D levels were eligible for meta-analysis. Vitamin D levels were lower in PsA patients compared to the healthy group (MD = -6.42 ; 95 % CI -8.31, -4.53 ; P < 0.01), while higher compared to Pso patients (MD = 2.37 ; 95 % CI 0.97, 3.78 ; P < 0.01). Included studies had moderate to low risk of bias. Conclusion: In conclusion, PsA patients have lower vitamin D levels than the general population. However, further studies are essential to understand the role of vitamin D in the development and treatment of PsA and the differences in vitamin D metabolism in PsA and Pso.
Izvorni jezik
Engleski
Znanstvena područja
Kliničke medicinske znanosti
POVEZANOST RADA
Ustanove:
KBC Split,
Medicinski fakultet, Split,
Mediteranski institut za istraživanje života
Profili:
Mislav Radić
(autor)
Andrea Gelemanović
(autor)
Marijana Vučković
(autor)
Josipa Radić
(autor)
Citiraj ovu publikaciju:
Časopis indeksira:
- Current Contents Connect (CCC)
- Web of Science Core Collection (WoSCC)
- Science Citation Index Expanded (SCI-EXP)
- SCI-EXP, SSCI i/ili A&HCI
- Scopus
- MEDLINE